A nasal spray to block infection of lung cells with SARS-CoV-2
A research team has developed a decoy capable of irreversibly blocking the SARS-CoV-2 virus, preventing it from infecting lung cells. This groundbreaking discovery could constitute an alternative therapeutic solution to vaccination.